APA (7th ed.) Citation

DC, S., N, A., I, B., JL, B., L, C., LM, D., . . . V, S. (2011). High-dose melphalan and autologous stem cell transplantation for AL amyloidosis: Recent trends in treatment-related mortality and 1-year survival at a single institution. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis, 18 Suppl 1, 127. https://doi.org/10.3109/13506129.2011.574354047

Chicago Style (17th ed.) Citation

DC, Seldin, et al. "High-dose Melphalan and Autologous Stem Cell Transplantation for AL Amyloidosis: Recent Trends in Treatment-related Mortality and 1-year Survival at a Single Institution." Amyloid : The International Journal of Experimental and Clinical Investigation : The Official Journal of the International Society of Amyloidosis 18 Suppl 1 (2011): 127. https://doi.org/10.3109/13506129.2011.574354047.

MLA (9th ed.) Citation

DC, Seldin, et al. "High-dose Melphalan and Autologous Stem Cell Transplantation for AL Amyloidosis: Recent Trends in Treatment-related Mortality and 1-year Survival at a Single Institution." Amyloid : The International Journal of Experimental and Clinical Investigation : The Official Journal of the International Society of Amyloidosis, vol. 18 Suppl 1, 2011, p. 127, https://doi.org/10.3109/13506129.2011.574354047.